Abstract:Background: Medulloblastomas (MBs) are one of the most common malignant brain tumor types in children. MB prognosis, despite improvement in recent years, still depends on clinical and biological risk factors. Metastasis is the leading cause of MB-related deaths, which highlights an unmet need for risk stratification and targeted therapy to improve clinical outcomes. Among the four molecular subgroups, sonic-hedgehog (SHH)-MB harbors clinical and genetic heterogeneity with a subset of high-risk cases. Recently, long non-coding (lnc)RNAs were implied to contribute to cancer malignant progression, but their role in MB remains unclear. This study aimed to identify pro-malignant lncRNAs that have prognostic and therapeutic significance in SHH-MB. Methods: The Daoy SHH-MB cell line was engineered for ectopic expression of MYCN, a genetic signature of SHH-MB. MYCN-associated lncRNA genes were identified using RNA-sequencing data and were validated in SHH-MB cell lines, MB tissue samples, and patient cohort datasets. SHH-MB cells with genetic manipulation of the candidate lncRNA were evaluated for metastatic phenotypes in vitro, including cell migration, invasion, sphere formation, and expressions of stemness markers. An orthotopic xenograft mouse model was used to evaluate metastasis occurrence and survival. Finally, bioinformatic screening and in vitro assays were performed to explore downstream mechanisms. Results: Elevated lncRNA LOXL1-AS1 expression was identified in MYCN-expressing Daoy cells and MYCN-amplified SHH-MB tumors, and was significantly associated with lower survival in SHH-MB patients. Functionally, LOXL1-AS1 promoted SHH-MB cell migration and cancer stemness in vitro. In mice, MYCN-expressing Daoy cells exhibited a high metastatic rate and adverse effects on survival, both of which were suppressed under LOLX1-AS1 perturbation. Integrative bioinformatic analyses revealed associations of LOXL1-AS1 with processes of cancer stemness, cell differentiation, and the epithelial-mesenchymal transition. LOXL1-AS1 positively regulated the expression of transforming growth factor (TGF)-β2. Knockdown of TGF-β2 in SHH-MB cells significantly abrogated their LOXL1-AS1-mediated prometastatic functions. Conclusions: This study proved the functional significance of LOXL1-AS1 in SHH-MB metastasis by its promotion of TGF-β2-mediated cancer stem-like phenotypes, providing both prognostic and therapeutic potentials for targeting SHH-MB metastasis.

LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2

Lysyl Oxidase-Like 1 Predicts the Prognosis of Patients with Primary Glioblastoma and Promotes Tumor Invasion Via EMT Pathway

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT

LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer

Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors

LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP

LOXL2 Upregulates Hypoxia‑inducible Factor‑1α Signaling Through Snail‑FBP1 Axis in Hepatocellular Carcinoma Cells.

Lkb1 Inhibits Lung Cancer Progression Through Lysyl Oxidase And Extracellular Matrix Remodeling

Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer

LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling

Expression of Lysyl Oxidase in Human Osteosarcoma and Its Clinical Significance: a Tumor Suppressive Role of LOX in Human Osteosarcoma Cells.

LOXL2 Serves As a Prognostic Biomarker for Hepatocellular Carcinoma by Mediating Immune Infiltration and Vasculogenic Mimicry.

LOXL3 Silencing Affected Cell Adhesion and Invasion in U87MG Glioma Cells

LOXL1 Exerts Oncogenesis and Stimulates Angiogenesis Through the LOXL1-FBLN5/αvβ3 Integrin/fak-Mapk Axis in ICC

The dual role of LOXL4 in the pathogenesis and development of human malignant tumors: a narrative review

Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.

The role of LOXL2 in tumor progression, immune response and cellular senescence: a comprehensive analysis

LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes

Aberrant Expression of GOLM1 Protects ALK+ Anaplastic Large Cell Lymphoma from Apoptosis by Enhancing BCL-XL Stability

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.